AstraZeneca to withdraw sales of Covid-19 vaccine globally

#astrazeneca #covidvaccinesideeffects #covidvaccine #covidshield

In a significant development for India's vaccination efforts, AstraZeneca, in collaboration with the Serum Institute of India (SII), is set to withdraw its COVID-19 vaccine, Covishield, from the country's drug shelves. This announcement comes amidst global changes in vaccine availability and ongoing legal challenges faced by the UK-based pharmaceutical company.
AstraZeneca, known for its partnership with the University of Oxford in developing the vaccine, has cited a "surplus of available updated vaccines" as the primary reason behind the withdrawal. This decision marks a shift in focus for the company, which has also faced legal action over alleged severe side effects of its vaccine.

Check full updates on Medical Dialogues

Also check out -
Medical Dialogues Academy, a renowned academic wing of Medical Dialogues - India's premier health and news online portal, proudly presents this comprehensive course tailored for healthcare professionals eager to delve into the realm of medical journalism.

📚 Explore More With Us:

Join us on this enlightening journey and become a part of a community pushing the boundaries of healthcare communication and reporting.
Follow us on